Pharmena

Pharmena Dividend

The Dividend of Pharmena (PHR.WA) as of Nov 6, 2026 is 0.85 PLN. In the previous year, Dividend was 0.11 PLN — a change of 641.65% (higher).

Dividend

0.85PLN

YoY

641.65%

Dividend yield

30.91 %

Last updated:

How much dividend does Pharmena 2026 pay?

According to the latest status from November 2026, Pharmena paid a total of 0.85 PLN per share in dividends within the last 12 months. With the current Pharmena price of 2.75 PLN, this corresponds to a dividend yield of 29.41 %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 30.91%. The dividend has grown at 20.2% per year over the past 15 years.

Historical Pharmena Dividends

Historical Pharmena Dividends
PaydateDividend
0.85PLN
0.11PLN
0.11PLN
0.11PLN
0.10PLN
0.04PLN
0.01PLN
0.05PLN
0.05PLN

The Pharmena Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2018
0.00 PLN
Jan 1, 2019
0.00 PLN
Jan 1, 2020
0.00 PLN
Jan 1, 2021
0.00 PLN
Jan 1, 2022
0.00 PLN
Jan 1, 2023
0.00 PLN
Jan 1, 2024
0.85 PLN
Jan 1, 2025
0.00 PLN
The Pharmena Dividend history
YEARDividendYoY
0.00PLN-100.00%
0.85PLN—
0.00PLN—
0.00PLN—
0.00PLN—
0.00PLN—
0.00PLN—
0.00PLN—
0.00PLN-100.00%
0.11PLN+9.09%
0.11PLN0.00%
0.11PLN+10.00%
0.10PLN+114.32%
0.04PLN+400.00%
0.01PLN-83.33%
0.05PLN0.00%
0.05PLN—
0.00PLN—
0.00PLN—
0.00PLN—

Is the Pharmena Dividend Safe?

Pharmena has been increasing the dividend for 2 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Pharmena dividend payout ratio

In 2025, Pharmena had a payout ratio of 182.20%. The payout ratio indicates the percentage of the company's profits that Pharmena distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
229.77 %
Jan 1, 2019
145.90 %
Jan 1, 2020
189.10 %
Jan 1, 2021
188.26 %
Jan 1, 2022
174.42 %
Jan 1, 2023
183.92 %
Jan 1, 2024
-750.17 %
Jan 1, 2025
182.20 %

Dividend Details

Understanding Pharmena's Dividend Distributions

Pharmena’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Pharmena's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Pharmena's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Pharmena’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Pharmena Stock analysis

What does Pharmena do? Pharmena SA develops and markets products based on 1-MNA, a patented physiological active substance. The company sells Dermena for hair loss, Dermena Plus for dandruff and hair loss, Accos for acne, Allerco for hypo-allergic body care, Thermi for burn and sunburn relief, and Revium for anti-wrinkle treatments. Pharmena collaborates with research centers in Europe, the US, and Canada on multidirectional studies. The company has a wholly owned subsidiary, Cortria Corporation, in the US, and its main shareholder is Pelion SA, with Polska Grupa Farmaceutyczna SA holding a 43.65% stake as of 2011. Pharmena SA's revenue comes from direct sales of its product lines to consumers and healthcare providers. Dermena and Dermena Plus target individuals with hair loss concerns, while Accos and Allerco appeal to those seeking acne and sensitive skin solutions. Thermi serves patients recovering from burns, and Revium attracts customers focused on anti-aging skincare. The company’s research partnerships with European, US, and Canadian institutions support product development and market positioning. The company operates through its subsidiary Cortria Corporation in the US, expanding its market reach. Polska Grupa Farmaceutyczna SA, a significant shareholder, likely influences strategic decisions. Pharmena’s product portfolio is structured around specific health and beauty segments, with Dermena and Revium targeting cosmetic and dermatological needs, and Thermi addressing medical recovery applications. Pharmena is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharmena stock

Over the past 12 months, Pharmena paid a dividend of 0.85 PLN . This corresponds to a dividend yield of about 30.91 %. For the coming 12 months, Pharmena is expected to pay a dividend of 0.85 PLN.

The current dividend yield of Pharmena is 30.91 %.

Pharmena pays a dividend, distributed in the months of June, August, April.

Pharmena paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.85 PLN are expected. This corresponds to a dividend yield of 29.41 %.

Pharmena is assigned to the 'Non-cyclical consumption' sector.

To receive the latest dividend of Pharmena from 4/24/2024 amounting to 0.85 PLN, you needed to have the stock in your portfolio before the ex-date on 4/9/2024.

The last dividend was paid out on 4/24/2024.

In the year 2024, Pharmena distributed 0.85 PLN as dividends.

The dividends of Pharmena are distributed in PLN.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Pharmena